The novel treatment of the medication represents a major advance in the handling of the condition. Different to existing drugs, tirzepatide targets multiple pathways – the GLP-1 hormone and GIP – resulting in https://tirzepatidepeptide238194.vblogetin.com/48132238/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment